Connect with a Global Community of 150+ GLP-1 Experts
The 3rd GLP-1 Based Therapeutics Summit offers an unparalleled platform to connect directly with 150+ senior leaders in the industry.
This highly exclusive delegation comprises executives from pharmaceutical giants, pioneering biotechs and influential academic institutions - all driving the future of the GLP-1 market.
As a partner, you can position your company at the forefront of this strategic shift and forge partnerships that will accelerate your growth and impact. Connect with a targeted audience dedicated to mastering multi-agonist design, improving tolerability, clinical trial design and the strategic expansion into neurological and cardiovascular indications.
This summit creates the ideal environment to cultivate meaningful collaborations and unlock the potential for transformative partnerships that will secure the 2026 pipeline.
What to Expect?
Raise Your Brand Awareness
Position your organization as a pioneer in next-generation GLP-1 therapeutics by ensuring your brand is visible to 150+ c-level executives, senior scientists, and strategic decision-makers dedicated to accelerating metabolic and neurodegenerative drug development
Distinguish Yourself from the Crowd
Differentiate your solutions and services in a fiercely competitive market by showcasing your breakthroughs to a focused audience actively seeking new technologies to gain a competitive edge beyond monotherapy
Generate Commercial Opportunities
Accelerate your business development objectives by directly engaging with decision-makers at major pharma and biotech companies by forging the crucial collaborations needed to secure your market position in the 2026 GLP-1 market
Uncover the Next Market Trend
Gain exclusive, front-line intelligence on the GLP-1 field, discovering emerging clinical and commercial data and strategies for high-value indication expansion into neurological disorders, cardiorenal protection and women's health
Brush Shoulders with Industry Experts
Directly network with 150+ key opinion leaders, speakers, and leading innovators, including representatives from major pharma, innovative biotechs ensuring you are part of the conversation defining the future of GLP-1 drug development
Key Services & Solutions
Our attendees from GLP-1 biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:
Preclinical CROs
With particular interest in models of obesity including, muscle models, to validate trial findings in preclinical models
Clinical CROs
Contract research organisations to assist with the planning and coordinating sites for clinical trials
Diagnostics & Imaging
Imaging (MRIs etc) for obesity, cardiovascular, renal, metabolic as a biomarker and endpoint
RWE & HEOR
Real world evidence, health economics outcomes research – data companies to collect and analyse the real-world data for trials
Hear What Our Past Sponsors Have to Say
The sessions were amazing and there was a very good opportunity to discuss and meet with all of the meeting participants
Senior Director, Antaros Medical AB
The quality of the program and participants, not to mention the number of opportunities to connect
Director, Scientific & Business Development, Cardiomedex
Audience Composition
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Presenting Slots
Panel Discussions
Exhibition Booths
Full Delegate List
Branding Opportunities
Networking Options
Drinks Reception
Bespoke Options
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Ezgi Vedat-Irikzade
Partnerships Director